(Q36429644)

14 August 2017

1 reference

title

The alphaVbeta6 integrin as a novel molecular target for colorectal cancer (English)

1 reference

14 August 2017

1 reference

Richard C Bates

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

821-828

1 reference

14 August 2017

cites work

Focus on colon cancer

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Molecular and biochemical markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

21 January 2018

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Targeting signal transduction pathways in colorectal cancer--more than skin deep

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Epithelial mesenchymal interactions in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

The role of integrins in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

The immunology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Expression of alpha(v)beta6 integrin in oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Reactive stroma in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.1.6.821

21 January 2018

Identifiers

DOI

10.2217/14796694.1.6.821

1 reference

14 August 2017

1 reference